Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056443
Filing Date
2021-11-12
Accepted
2021-11-12 07:03:36
Documents
63
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alrn-10q_20210930.htm   iXBRL 10-Q 2608658
2 EX-31.1 alrn-ex311_8.htm EX-31.1 16320
3 EX-31.2 alrn-ex312_7.htm EX-31.2 16178
4 EX-32.1 alrn-ex321_10.htm EX-32.1 7926
5 EX-32.2 alrn-ex322_6.htm EX-32.2 7024
  Complete submission text file 0001564590-21-056443.txt   7790604

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA alrn-20210930.xsd EX-101.SCH 41455
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alrn-20210930_cal.xml EX-101.CAL 38007
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alrn-20210930_def.xml EX-101.DEF 132131
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE alrn-20210930_lab.xml EX-101.LAB 364319
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alrn-20210930_pre.xml EX-101.PRE 270004
11 EXTRACTED XBRL INSTANCE DOCUMENT alrn-10q_20210930_htm.xml XML 1355783
Mailing Address 285 SUMMER STREET UNIT 101 BOSTON MA 02210
Business Address 285 SUMMER STREET UNIT 101 BOSTON MA 02210 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38130 | Film No.: 211399482
SIC: 2834 Pharmaceutical Preparations